| Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2 K Mozdzanowska, JQ Feng, M Eid, G Kragol, M Cudic, L Otvos Jr, ... Vaccine 21 (19-20), 2616-2626, 2003 | 278 | 2003 |
| Intracellular targets of antibacterial peptides M Cudic, L Otvos Jr Current drug targets 3 (2), 101-106, 2002 | 231 | 2002 |
| Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major … AM Vlad, S Muller, M Cudic, H Paulsen, L Otvos Jr, FG Hanisch, OJ Finn The Journal of experimental medicine 196 (11), 1435-1446, 2002 | 197 | 2002 |
| Identification of crucial residues for the antibacterial activity of the proline‐rich peptide, pyrrhocoricin G Kragol, R Hoffmann, MA Chattergoon, S Lovas, M Cudic, P Bulet, ... European journal of biochemistry 269 (17), 4226-4237, 2002 | 163 | 2002 |
| Development of novel antibacterial peptides that kill resistant isolates M Cudic, BA Condie, DJ Weiner, ES Lysenko, ZQ Xiang, O Insug, P Bulet, ... Peptides 23 (12), 2071-2083, 2002 | 139 | 2002 |
| Mitochondrial targeted cytochrome P450 2E1 (P450 MT5) contains an intact N terminus and requires mitochondrial specific electron transfer proteins for activity MA Robin, HK Anandatheerthavarada, JK Fang, M Cudic, L Otvos, ... Journal of Biological Chemistry 276 (27), 24680-24689, 2001 | 119 | 2001 |
| The roles of substrate thermal stability and P2 and P1′ subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity D Minond, JL Lauer-Fields, M Cudic, CM Overall, D Pei, K Brew, R Visse, ... Journal of biological chemistry 281 (50), 38302-38313, 2006 | 105 | 2006 |
| Extracellular proteases as targets for drug development M Cudic, GB Fields Current Protein and Peptide Science 10 (4), 297-307, 2009 | 96 | 2009 |
| Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design DM Beckwith, M Cudic Seminars in immunology 47, 101389, 2020 | 89 | 2020 |
| Targeted drug delivery utilizing protein-like molecular architecture EM Rezler, DR Khan, J Lauer-Fields, M Cudic, D Baronas-Lowell, ... Journal of the American Chemical Society 129 (16), 4961-4972, 2007 | 87 | 2007 |
| Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse K Mozdzanowska, D Zharikova, M Cudic, L Otvos, W Gerhard Virology journal 4, 1-14, 2007 | 84 | 2007 |
| Chemical synthesis, antibacterial activity and conformation of diptericin, an 82‐mer peptide originally isolated from insects M Cudic, P Bulet, R Hoffmann, DJ Craik, L Otvos Jr European journal of biochemistry 266 (2), 549-558, 1999 | 75 | 1999 |
| In vitro and in vivo activity of an antibacterial peptide analog against uropathogens M Cudic, CV Lockatell, DE Johnson, L Otvos Jr Peptides 24 (6), 807-820, 2003 | 72 | 2003 |
| Design–functionality relationships for adhesion/growth-regulatory galectins AK Ludwig, M Michalak, Q Xiao, U Gilles, FJ Medrano, H Ma, ... Proceedings of the National Academy of Sciences 116 (8), 2837-2842, 2019 | 66 | 2019 |
| Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates D Minond, M Cudic, N Bionda, M Giulianotti, L Maida, RA Houghten, ... Journal of Biological Chemistry 287 (43), 36473-36487, 2012 | 63 | 2012 |
| Primary structure and in vitro antibacterial properties of the Drosophila melanogaster attacin C Pro-domain D Rabel, M Charlet, L Ehret-Sabatier, L Cavicchioli, M Cudic, L Otvos, ... Journal of Biological Chemistry 279 (15), 14853-14859, 2004 | 63 | 2004 |
| Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity N Bionda, M Stawikowski, R Stawikowska, M Cudic, F López‐Vallejo, ... ChemMedChem 7 (5), 871-882, 2012 | 62 | 2012 |
| An insect antibacterial peptide-based drug delivery system L Otvos, M Cudic, BY Chua, G Deliyannis, DC Jackson Molecular pharmaceutics 1 (3), 220-232, 2004 | 55 | 2004 |
| Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences D Minond, JL Lauer-Fields, M Cudic, CM Overall, D Pei, K Brew, ML Moss, ... Biochemistry 46 (12), 3724-3733, 2007 | 50 | 2007 |
| Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates R Stawikowska, M Cudic, M Giulianotti, RA Houghten, GB Fields, ... Journal of Biological Chemistry 288 (31), 22871-22879, 2013 | 49 | 2013 |
